DARWIN Biomed develops advanced assistive robotics and intelligent systems for health, longevity and improved quality of life, including the MICHELANGELO smart walker. The company positions itself as a deep-tech transfer initiative that integrates robotics and advanced intelligence with a person-centered approach to address mobility and aging challenges. DARWIN Biomed reported a headcount of four (three founding partners and one employee) and plans to double staff within 18 months. Funds from the recent Pre-Seed round are earmarked to accelerate technology development, clinical validation and regulatory approvals. The company aims to obtain CE and FDA clearances and initiate commercialization across the EU-27 and the United States. DARWIN Biomed emphasizes collaboration with industrial and regional stakeholders to scale its solution and generate qualified employment and impact within the innovation ecosystem.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2026